The list of vital and essential medicines has been supplemented with new items. The list includes three combination drugs for the treatment of various viral and bacterial infections and infectious and inflammatory diseases. Both lists also include two new drugs from Biocad for patients with multiple sclerosis. All drugs included in the lists are produced in a full cycle in Russia.
The updated list now includes three combination drugs used to treat patients with a range of viral and bacterial infections, as well as infectious and inflammatory diseases. This:
cefepime + sulbactam,
lamivudine + phosphazide,
tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate.
In addition, the list of vital and essential drugs includes two new drugs needed by patients with multiple sclerosis:
sampeginterferon beta-1a, BCD-054,
divosilimab.
